Phase I clinical, pharmacokinetic, and pharmacodynamic study of KOS-86
- This topic has 0 replies, 1 voice, and was last updated 12 years, 8 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
Phase I clinical, pharmacokinetic, and pharmacodynamic study of KOS-862 (Epothilone D) in patients with advanced solid tumors and lymphoma.
Viewing 1 post (of 1 total)
- The forum ‘New Developments’ is closed to new topics and replies.